U.K. « Science and Enterprise

National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
about 3 hours ago
New post on Science and Enterprise: NSF Funds AI Covid-19 Drug Combo Simulation https://t.co/j7DsIncCUk #Science #Business
about 3 hours ago
A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for… https://t.co/CVwEr6dEoU
about 3 hours ago
New post on Science and Enterprise: Gene-Edited Transplant Organ Company Raises $125M https://t.co/UYlUcA8Z5X #Science #Business
about 7 hours ago
A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-1… https://t.co/82gYsU3rvr
about 1 day ago

New Trial Testing Reformulated Covid-19 Vaccine

By Alan, on February 22nd, 2021%

Two drug makers are beginning a clinical trial to test their reformulated vaccine against Covid-19 disease, particularly among older populations. . . . → Read More: New Trial Testing Reformulated Covid-19 Vaccine

New Funds Backing Global Health, Early-Stage Ventures

By Alan, on February 18th, 2021%

Three new funds are financing start-up companies creating solutions for health issues in less-developed countries and early-stage life science businesses. . . . → Read More: New Funds Backing Global Health, Early-Stage Ventures

Biotech, UK Govt to Design Covid-19 Variant Vaccines

By Alan, on February 5th, 2021%

A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations. . . . → Read More: Biotech, UK Govt to Design Covid-19 Variant Vaccines

Cannabidiol Drug Maker Acquired in $7.2B Deal

By Alan, on February 4th, 2021%

A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal. . . . → Read More: Cannabidiol Drug Maker Acquired in $7.2B Deal

One-Dose Covid-19 Vaccine Shown to Prevent Hospitalization

By Alan, on February 3rd, 2021%

Results from four international clinical trials show high disease prevention rates from one dose of the Oxford-AstraZeneca Covid-19 vaccine. . . . → Read More: One-Dose Covid-19 Vaccine Shown to Prevent Hospitalization

Institutions Join Global Health Breakthrough Network

By Alan, on January 28th, 2021%

Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles. . . . → Read More: Institutions Join Global Health Breakthrough Network

Trial Testing Multi-Company Covid-19 Therapy

By Alan, on January 27th, 2021%

A clinical trial already underway is expanding to test a combination of two synthetic antibodies from different companies as a treatment for Covid-19 infections. . . . → Read More: Trial Testing Multi-Company Covid-19 Therapy

Infographic – Most Americans Wearing Mask in Public

By Alan, on January 23rd, 2021%

Wearing a face mask has become a hot-button public controversy in the U.S., but a continuing survey shows Americans by and large are wearing masks in public. . . . → Read More: Infographic – Most Americans Wearing Mask in Public

Drug Maker Gains Access to Hidden Protein Immunotherapies

By Alan, on January 12th, 2021%

Global drug maker Boehringer Ingelheim is gaining access to an immunotherapy technology that targets usually hidden proteins to attack cancer cells. . . . → Read More: Drug Maker Gains Access to Hidden Protein Immunotherapies

Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant

By Alan, on December 18th, 2020%

A biotechnology company and university infectious disease lab are developing a Covid-19 vaccine given as a solid dose implant under the skin. . . . → Read More: Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise